Related Experiment Video
Updated: Apr 5, 2026
Multiplex Detection of Bacteria in Complex Clinical and Environmental Samples using Oligonucleotide-coupled Fluorescent Microspheres
Published on: October 23, 2011
Multiplex Molecular Panels for Diagnosis of Gastrointestinal Infection: Performance, Result Interpretation, and
Abstract:
Gastrointestinal disease is a major cause of morbidity and mortality worldwide, especially among young children and immunocompromised patients. Diarrhea may result from infection with a variety of microbial pathogens, including bacteria, viruses, or parasites. Historically, the diagnosis of infectious diarrhea has been made using microscopy, antigen tests, culture, and real-time PCR. A combination of these traditional tests is often required due to the inability to distinguish between infectious etiologies based on the clinical presentation alone. Recently, several multiplex molecular assays have been developed for the detection of gastrointestinal pathogens directly from clinical stool samples. These panels allow for the detection and identification of up to 20 pathogens in as little as 1 h. This review will focus on the multiplex molecular panels that have received clearance from the FDA for the diagnosis of diarrheal disease and will highlight issues related to test performance, result interpretation, and cost-effectiveness of these new molecular diagnostic tools.
Insights
Multiplex molecular assays offer rapid, comprehensive detection of gastrointestinal pathogens, improving infectious diarrhea diagnosis. These FDA-cleared panels enhance patient care by identifying multiple causes of diarrheal disease efficiently.
Area of Science:
- Microbiology
- Infectious Diseases
- Molecular Diagnostics
Background:
- Gastrointestinal diseases cause significant global morbidity and mortality, particularly in vulnerable populations.
- Infectious diarrhea diagnosis traditionally relies on multiple, often slow, laboratory methods.
- Clinical presentation alone is insufficient for identifying specific infectious diarrhea etiologies.
Purpose of the Study:
- To review FDA-cleared multiplex molecular assays for diagnosing diarrheal disease.
- To evaluate the performance, interpretation, and cost-effectiveness of these advanced diagnostic tools.
Main Methods:
- Focus on multiplex molecular panels for detecting gastrointestinal pathogens in stool samples.
- Analysis of assays with FDA clearance for diarrheal disease diagnosis.
Main Results:
- Multiplex assays can identify up to 20 pathogens within an hour.
- These tools offer a significant advancement over traditional diagnostic methods.
Conclusions:
- Multiplex molecular assays represent a significant improvement in diagnosing infectious diarrhea.
- Further evaluation of performance, interpretation, and cost-effectiveness is crucial for widespread adoption.
